PTGS2 and metabolic dysfunction-associated steatotic liver disease: Portulaca oleracea and its main component, myricetin, alleviate non-alcoholic fatty liver disease by downregulating and inhibiting prostaglandin-endoperoxide synthase 2 (PTGS2) (He et al., 2021).